Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma (ip) sprl - factor ix, human - powder and solvent for solution for injection - 1000 international unit(s) - blood coagulation factors; coagulation factor ix

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma (ip) sprl - human factor viii; von willebrand factor human - powder and solvent for solution for injection - 500/500 international unit(s) - blood coagulation factors; von willebrand factor and coagulation factor viii in combination

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma (ip) sprl - human factor viii; von willebrand factor human - powder and solvent for solution for injection - 1000/1000 international unit(s) - blood coagulation factors; von willebrand factor and coagulation factor viii in combination

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

octapharma benelux sa-nv - protein s 12 iu/ml - 32 iu/ml; human coagulation factor x 18 iu/ml - 30 iu/ml; human coagulation factor ix 25 iu/ml; human coagulation factor ii 14 iu/ml - 38 iu/ml; protein c 7 iu/ml - 31 iu/ml; human coagulation factor vii 9 iu/ml - 24 iu/ml - powder and solvent for solution for infusion - 500 iu - human coagulation factor ii 14.5 iu/ml; human coagulation factor ix 25 iu/ml; human coagulation factor vii 16.5 iu/ml; human coagulation factor x 24 iu/ml; protein c 19 iu/ml; protein s 19.5 iu/ml - coagulation factor ix, ii, vii and x in combination

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

octapharma benelux sa-nv - human coagulation factor ii 14 iu/ml - 38 iu/ml; human coagulation factor ix 25 iu/ml; protein c 13 iu/ml - 31 iu/ml; human coagulation factor vii 9 iu/ml - 24 iu/ml; human coagulation factor x 18 iu/ml - 30 iu/ml; protein s 12 iu/ml - 32 iu/ml - powder and solvent for solution for infusion - 1000 ui - human coagulation factor ii; human coagulation factor vii; human coagulation factor ix 25 iu/ml; human coagulation factor x; protein c; protein s - coagulation factor ix, ii, vii and x in combination

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - coagulation factor ii (human); coagulation factor vii (human); coagulation factor ix (human); coagulation factor x (human); protein c; protein s - kit - 760unit; 480unit; 500unit; 600unit; 620unit; 640unit - coagulation factor ii (human) 760unit; coagulation factor vii (human) 480unit; coagulation factor ix (human) 500unit; coagulation factor x (human) 600unit; protein c 620unit; protein s 640unit - hemostatics

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - coagulation factor ii (human); coagulation factor vii (human); coagulation factor ix (human); coagulation factor x (human); protein c; protein s - kit - 1520unit; 960unit; 1000unit; 1200unit; 1240unit; 1280unit - coagulation factor ii (human) 1520unit; coagulation factor vii (human) 960unit; coagulation factor ix (human) 1000unit; coagulation factor x (human) 1200unit; protein c 1240unit; protein s 1280unit - hemostatics

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor ix -

Israel - English - Ministry of Health

takeda israel ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for injection/infusion - factor viii inhibitor bypassing fraction 1000 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors .control of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available.

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - factor ix, human - pdr+solv for soln for inj - 500 international unit - blood coagulation factors